Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals is a fully integrated biopharmaceutical company that is applying a unique approach to gene science based on Nobel Prize-winning technology to discover and develop precise medicines for people with serious, chronic conditions. Using a patient driven approach, we are working to discover and develop innovative medicines to safely and effectively treat disease and improve patient lives.Through our Genome5000™ program, Lexicon scientists spent more than a decade studying the role and function of nearly 5,000 genes to pinpoint the key targets for drug development. 

Bank Name Lexicon Pharmaceuticals, Inc.
Stock Exchange NASDAQ
Symbol LXRX
Sector Healthcare
Industry Major Pharmaceuticals
Country United States
World Region Amarica
CEO Mr. Lonnel Coats
Employees 174
Website www.lexpharma.com
Registered Year 1995